The company’s superior execution in recent quarters makes it worthy of tracking. We see huge business opportunities emerging from the parent and group companies; investors can buy the stock on market dips
While in the near term, the equity market looks fragile, Gland Pharma makes a cut for the longer haul. This is because of the rising prevalence of chronic diseases and growth of biologics, wherein injectables have a role in treatment and drug delivery
Management sees global auto industry contracting in FY23 as well, but confident of SEL outperforming the industry by 5-10 percent. We advise investors to accumulate this stock for the long term
The significant correction in the stock price of Zensar has rendered the valuation extremely attractive
JK Paper is well positioned to benefit from the sector tailwinds given market leading position and input cost pressures. Capacity expansion will fuel earnings visibility and could offer reasonable upside over the medium term.
Castrol enjoys a 20 percent market share and personal mobility accounts for around 45 percent of the total volume sold
Investors can play the shift from unorganised play to the organised, given that customers are preferring large players
The current market has clearly punished stocks that have inflated valuations. Dixon is no exception as the stock has fallen about 40 percent in the past 6-8 months. Besides, the stock had a massive rundown following the ED raids on Xiaomi India
With the revenue visibility over the medium term, and no material affect on the margins, construction space should deliver better earnings performance
The stock has corrected more than 50 percent from its 52-week high price seen in mid-March’22
Revenue growth of the liquor maker was quite solid, but its operating performance turned weaker hit by inflationary cost pressures
Thanks to the significant underperformance, the stock of Coforge is now reasonably valued and offers good risk-reward
It is one of the rare gems in the listed space to play on the megatrend of electrification of vehicles
Asset quality issues are behind. The bank has put in substantial efforts in diversifying and de-risking its asset book away from unsecured micro-finance
The bank management had guided to better return on assets (ROA) at 1.5 percent by FY23 and has already delivered 1.4 percent in FY22
As per FOMC projections, the Federal Funds rate can reach 3.4 percent by the end of this calendar year. This is significantly higher than the March projection of 1.9 percent and implies about 50 bps rate hike each in the remaining four meetings this year
Relatively better growth visibility and the recent steps towards diversification support our long-term conviction on this scrip.
Given the strong earnings trajectory and undervaluation, we see a decent upside in the stock of Ujjivan SFB for long-term investors.
While there are near term headwinds in the form of subdued demand owing to increased prices, the long term outlook for the retail sector is bright. Market weakness should be used to add quality stocks in the portfolio
Fourth-quarter performance was better than September’s as international gas prices eased from $50/MMBtu to $20-25/MMBtu. However, the shortage of APM gas continued in the quarter
Rising share of light-emitting diodes (LEDs), addition of new clients and new business from existing clients are expected to augur well for the company
Investors have been taking advantage of the correction in the market; also DIIs have been net buyers for 16 consecutive months even as FIIs have been net sellers.
We advise strong caution on UltraTech and Shree Cement as the entry of Adani poses the biggest risk to their market share as well as super-rich valuation
In an inflationary environment with a looming threat of an economic slowdown, the decline in valuation usually precedes the downward earnings revisions
Fed Funds futures are pricing in a 75 bps hike in one of the meetings till September